Restoration of Wnt signaling by treatment with a cGMP-elevating agent or osteoblast-specific expression of a constitutively active PKG2 prevents glucocorticoid-induced osteoporosis in mouse models. This evidence concerns the gene PRKG2 and osteoporosis.